At the Limits - Leading Medical Education

Leading medical education across the globe. Events strictly for HCPs, with independent content funded by industry.

[MS Society UK @mssocietyuk]

Thanks to everyone who stopped to say hello to us at the MS Nurses @atthelimits meeting in London today.

We’ve been chatting to lots of nurses about #MS and the support our MS Helpline offers.

Stop by our stand if you’re coming along on Saturday 16 November @RCPhysicians

[At the Limits - Leading Medical Education @atthelimits]

Places are still available: https://t.co/PoFL8XWXCd for the ‘MS at the Limits 2024’ conference taking place at the Royal College of Physicians in London on 24 & 25 October. Bringing together a faculty of the world’s leading #MS specialists the event is for #HCPs only and funded by the pharma industry. For full funding disclosure, and programme go https://t.co/PoFL8XWXCd #MSATL2024

[At the Limits - Leading Medical Education @atthelimits]

REGISTER NOW for the ‘MS at the Limits 2024’ conference taking place at the Royal College of Physicians in London on 24 & 25 October. Bringing together a faculty of the world’s leading MS specialists the event is for HCPs only and funded by the pharma industry. For full funding disclosure, the programme and registration go to https://t.co/NIzZhgMXkN @prof_mouse

[Hatter Cardiovascular Institute, UCL @HatterCardioUCL]

🧐 UCL - The Hatter Cardiovascular Institute looking for Clinical Cardiovascular PhD Candidate

👩‍🔬Apply now to complete a cardiovascular PhD while working part-time at the Wellington Hospital.

💥Closes 16th February 💥
https://t.co/1zmSlXiF5N

[ECTRIMS @ECTRIMS]

#ECTRIMS2024 will be a very special congress for ECTRIMS. It will mark 40 years since we began bringing people together in the pursuit of improved treatment options for people with #MS.

🗓️ 18-20 September | 🇩🇰 Copenhagen, Denmark
More details here: https://t.co/IfZJP05xWM

[Laura Airas @LauraAiras1]

MS At The Limits. I took my maiden journey in steering or co-chairing this ship of #MSATL2023 in London. A 2-day meeting packed full of cutting-edge science and good discussions. Join us at #MSATL2024 Brilliant co-chair Professor Jiwon Oh left before pic taking time. ✈️😊

[Klaus Schmierer @KlausSchmierer]

🔥 The #BartsMSNavigator Now on the @NHSBartsHealth website: https://t.co/f2d1nfTxPm Thank you all #Team11D, and particularly @AndreaStennett @Kimberley_AP @joelamathews👏

A #BartsMS #Navigator https://t.co/jD1JfLDE8k @the_MSBlog

[Klaus Schmierer @KlausSchmierer]

📢For #HCPs: #MS at the limits #MSATL2023 https://t.co/kEDXujh1Pv @NCMSmeeting @mssocietyuk @mssociety @MSTrust @QSMSCENTRE @AttackMS_trial @QMUL @GavinGiovannoni @prof_mouse @icometrix @hwiendl @es_arman @HarvardChanSPH @MStranslate @MSJ_Research @MSIntFederation @ECTRIMS

[Prof Rachel Batterham @ProfBatterhamMD]

I was honoured and privileged to be asked to give the #HatterAwardLecture as part of the Cardiology, Diabetes and Nephrology #atthelimits meeting on obesity pharmacotherapies at @RCPhysicians today and was presented with this fantastic award plaque to commemorate the achievement

[Daniel J Drucker @DanielJDrucker]

The authors propose that targeting the mitochondrial protein HIGD1A may provide a promising approach to combat #obesity and obesity-associated disorders based on its positive role in adipose browning @CellReports https://t.co/GY5eDgB7gt

[Eric Topol @EricTopol]

Not every day you see an anti-obesity drug that has an average of >24% body weight loss
🆕 @NEJM #ADA2023
https://t.co/dzh5dKgV8i
Triple receptor agonist weight loss exceeds prior GLP-1 drugs (and dual receptor agents) and has yet to plateau

[At the Limits - Leading Medical Education @atthelimits]

Follow us on Linkedin for our latest event news

https://t.co/BCYW8hEHLi

[Humberto Rodriguez R @DrHumbertoRdzR]

I enjoyed ‘at the limits' meeting in London. Bringing together specialists in Cardiology, Endocrinology, and Nephrology sparks interdisciplinary conversations that undoubtedly enhance patient care. Excellent presentations, including one from @KatherineTuttl8

[Michelle Allan @drmeallan]

An incredible tour de force talk on #obesity from the always inspiring @ProfBatterhamMD, this year’s Hatter Award recipient @atthelimits @HatterCardioUCL. #CDNATL23

[The Lancet @TheLancet]

The Lancet has been in print for 200 years!

Much has changed since 1823, but our founding principle remains—through advancing research and science, we can drive change for the greater good.

Discover how we're marking #Lancet200: https://t.co/QQxtJ7AArA 🧵

[Cambridge University Hospitals NHS @CUH_NHS]

Researchers at @Cambridge_Uni and @CUH_NHS have found that a common drug used to treat liver disease could prevent Covid infection.

📺 Watch BBC Look East tonight at 6:30pm
📖 Read on our website here: https://t.co/haISLqyEHA

[Daniel J Drucker @DanielJDrucker]

Dinner time metabolism talk in Denmark-eat your cauliflower, Brussel sprouts and broccoli, never mind the fries and Rösti #obesity #T2D @Diabetes_ADA @DDA_Denmark https://t.co/aR2M9Rhodq

[BBC London @BBCLondonNews]

Imperial College London has become the first medical school in the UK to use VR as part of their curriculum to train future doctors. Medical students wear headsets to immerse themselves in emergency situations and make life or death decisions.

Read more: https://t.co/gav4O3fJhf

[The Lancet Global Health @LancetGH]

New Research: The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis https://t.co/6pXaU37WFb (1/2)

[Daniel J Drucker @DanielJDrucker]

Here actions of GLP-2 on bone and gut structure and function are preserved in the 6-month-old male senile osteoporosis model of senescence-accelerated mouse prone 6 (SAMP6) mice https://t.co/rS1iZ8xdSg